TY  - JOUR

T1  - Health economics and patient outcomes of hematopoietic stem cell transplantation versus disease-modifying therapies for relapsing remitting multiple sclerosis in the United States of America

JO  - Multiple Sclerosis and Related Disorders

PY  - 2020/10/01

AU  - Burt RK

AU  - Tappenden P

AU  - Han X

AU  - Quigley K

AU  - Arnautovic I

AU  - Sharrack B

AU  - Snowden JA

AU  - Hartung D

ED  - 

DO  - DOI: 10.1016/j.msard.2020.102404

PB  - Elsevier BV

VL  - 45

Y2  - 2024/12/21

ER  -